Position in MYGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,567,313
+$1,897,133 QoQ
Shares Held
449,617
+201.9% QoQ
Ownership
0.476%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2
of 29 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OP Asset Management Ltd holds $87,444,164 across 16 Diagnostics & Research names. MYGN ranks #10 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
42,228 | $21,171,430 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
31,087 | $16,365,440 | |
| 3 | DHR |
Danaher Corp /De/
|
71,589 | $13,636,272 | |
| 4 | A |
Agilent Technologies, Inc.
|
33,520 | $4,452,461 | |
| 5 | NTRA |
Natera, Inc.
|
15,341 | $4,164,314 | |
| 6 | WAT |
Waters Corp /De/
|
10,961 | $4,110,813 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
18,990 | $3,669,247 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
2,345 | $2,995,760 |
All Filings in MYGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,567,313 | 449,617 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $670,180 | 148,929 | Shares | Sole | 2026-04-10 | |
| 2025-09-30 | $78,488 | 10,856 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||